Original-Research

MHP Hotel AG (von NuWays AG): BUY 19.09.2025, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
MHP Hotel 1,355 EUR -2,52 % Lang & Schwarz

^

Original-Research: MHP Hotel AG - from NuWays AG

19.09.2025 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to MHP Hotel AG

Company Name: MHP Hotel AG

ISIN: DE000A3E5C24

Reason for the research: Preview / Review

Recommendation: BUY

from: 19.09.2025

Target price: EUR 3.00

Target price on sight of: 12 months

Last rating change:

Analyst: Philipp Sennewald

H1 preview: Strong growth & margin expansion expected

Next Monday, MHP will release its H1 report, which we expect to come in

strong following the already released hotel performance figures for Q2. In

detail:

H1 sales are seen to increase 12.2% yoy to EUR 79.0m, carried by a strong

development in Logis sales, which were up 14% yoy to EUR 60.1m according to

the hotel performance reports. This was mainly driven by higher occupancy

rates (eNuW: +1pp yoy in H1), another 8% (eNuW) improvement of the ADR to EUR

221 as well as the initial effect of the Koenigshof. The result is

particularly impressive given the absence of major one-off events like the

2024 Euros or large concerts series (e.g. Adele in Munich). F&B sales also

grew 11% yoy to EUR 16.3m, while the other sales segment should have remained

stable yoy.

This should have resulted in the first positive H1 EBITDA since the listing.

In fact, H1 EBITDA is expected at EUR 2.1m (H1'24: EUR -1.5m), implying a 2.7%

margin. In our view, this clearly displays positive operating leverage, even

during the seasonally softer H1.

On this basis, we expect management to confirm the FY25 outlook of c. EUR 180m

sales (eNuW: EUR 185m) and EBITDA of EUR 15m (eNuW: EUR 15.3m/ EUR 10.3m adj. EBITDA

excl. key money payments). In our view, this is absolutely in reach,

considering the historically stronger H2, the initial impact from the Conrad

in Hamburg (283 additional rooms, >10% increase on group level) as well as

the ramp-up of the Koenigshof. Based on our H1 estimates, the guidance

implies 11.5% yoy H2 sales growth as well as an EBITDA margin of 12.8% (vs

13.1% in H2'24), which again is reasonable, in our view.

At least equally important, however, is what lies ahead for MHP. Following

the successful capital increase in early Q3 (EUR 4.5m gross proceeds at EUR 1.45

per share), the company is now well-positioned to further expand its

portfolio. The timing seems perfect, given that the current challenges

several peers are facing should create attractive opportunities for MHP.

With industry-leading KPIs and approximately EUR 10m in available funds, MHP

is well-placed to secure some attractive locations in the coming quarters.

Note that aside from the already planned openings in Hamburg and Stuttgart,

we do not consider any portfolio additions in our model, indicating that any

announcements would result in further upside.

Besides taking over hotels and operating them under a top-tier hotel brand

(e.g. Marriott or Hilton), we expect MHP to also further roll out its own

boutique brand MOOONS, following the promising performance of its first

location in Vienna (11% EBITDA margin in FY24).

Overall, we maintain our strong conviction of the investment case, which is

supported by the company's current EV/adj. EBITDA and FCFY metrics. We

therefore reiterate our BUY rating and keep our PT unchanged at EUR 3.00 based

on DCF.

You can download the research here:

https://eqs-cockpit.com/c/fncls.ssp?u=ca59c2fed068b3ec2530ce1ecd51a56d

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---------------------------------------------------------------------------

2200066 19.09.2025 CET/CEST

°

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News

15:36 Uhr • Artikel • dpa-AFX

15:31 Uhr • Artikel • dpa-AFX

15:20 Uhr • Artikel • dpa-AFX

15:11 Uhr • Artikel • dpa-AFX

15:08 Uhr • Artikel • dpa-AFX

14:56 Uhr • Artikel • dpa-AFX

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer